TENDRIL DX MODEL 1388T & 1388K ENDOCARDIAL PACING LEADS
ABBOTT MEDICAL · Decision date Jun 20, 1997
What did the FDA approve?
FDA database entry P960013 records an approval decision dated June 20, 1997, for the Tendril DX Models 1388T and 1388K endocardial, steroid-eluting, screw-in pacing leads and the Ventritex Assure AFS Models 7010T and 7010K endocardial, steroid-eluting screw-in pacing leads. The applicant is listed as Abbott Medical, and the device category is drug-eluting permanent right ventricular or right atrial pacemaker electrodes.
The source statement describes these devices as indicated for use with a compatible pulse generator to provide permanent pacing and sensing in either the atrium or ventricle. This reported purpose is distinct from independent proof of safety or clinical effectiveness. The entry does not identify a supplement type or reason, so no relationship to a prior PMA scope change can be established from the supplied fields.
FDA approval order statement
APPROVAL FOR THE TENDRIL(R) DX MODELS 388T/K ENDOCARDIAL, STEROID ELUTING, SCREW-IN PACING LEADS AND VENTRITEX ASSURE(TM) AFS MODELS 7010T/K ENDOCARDIAL, STERIOID ELUTING SCREW-IN PACING LEADS. THESE DEVICES ARE INDICATED FOR USE IN COMBINATION IWTH A COMPATIBLE PULSE GENERATOR TO PROVIDE PERMANENT PACING AND SENSING IN EITHER THE ATRIUM OR VENTRICLE.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 20, 1997
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P960013
- Regulatory pathway
- Premarket approval application
- Applicant
- ABBOTT MEDICAL
- Product code
- NVN
- Decision code
- APPR
- Decision date
- Jun 20, 1997
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Applicant
- Abbott Medical
- Product code
- NVN
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P960013 received
Application receipt date recorded by FDA.
P960013 · FDA decision
APPR
P960013/S135 · Related supplement
Motorized Outer Tubing Cutter for UltiPace Leads
Timeline entries are records held by MedtechLedger for P960013. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960013
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC SELECTSECURE LEAD MODEL 3830P030036/S162 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 16, 2026 | FDA |
| Medtronic Cardiac Rhythm Disease Management | PMA approval | Aug 3, 2005 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91335
Sources and methodology
- Original FDA record: P960013
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

